Clinical data | |
---|---|
AHFS/ Drugs.com | International Drug Names |
Routes of administration | IV |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C19H27N5O5 |
Molar mass | 405.455 g·mol−1 |
3D model ( JSmol) | |
| |
| |
(verify) |
Nifekalant ( INN) is a class III antiarrhythmic agent approved in Japan for the treatment of arrhythmias and ventricular tachycardia. [1] It has the brand name Shinbit.
Clinical data | |
---|---|
AHFS/ Drugs.com | International Drug Names |
Routes of administration | IV |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C19H27N5O5 |
Molar mass | 405.455 g·mol−1 |
3D model ( JSmol) | |
| |
| |
(verify) |
Nifekalant ( INN) is a class III antiarrhythmic agent approved in Japan for the treatment of arrhythmias and ventricular tachycardia. [1] It has the brand name Shinbit.